U.S. Life Sciences Stock News

NasdaqGS:PEP
NasdaqGS:PEPBeverage

Is It Time To Reassess PepsiCo (PEP) After Its Recent Share Price Rally?

If you are wondering whether PepsiCo's current share price still offers value, this article will walk through what the numbers say and how that could fit into your own portfolio thinking. The stock last closed at US$169.17, with returns of 2.9% over 7 days, 16.0% over 30 days, 18.9% year to date, 16.1% over 1 year and 9.0% over 3 years, while the 5 year return sits at 52.8%. Recent coverage has focused on PepsiCo's position in global beverages and snacks, along with ongoing brand strength...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Record Q1 Profits And Insider Sale Might Change The Case For Investing In Cirrus Logic (CRUS)

Earlier this month, Cirrus Logic reported record net income and strong earnings per share for Q1 2026, while Executive Vice President of Global Operations Justin E. Dougherty sold 3,000 shares on February 11, reducing his direct holdings by 33.80%. This combination of robust profitability and a sizable insider sale highlights a tension between positive operating performance and potential questions about internal confidence in the company’s outlook. We’ll now examine how Dougherty’s sizable...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Is Cooper Companies (COO) Fairly Priced After Mixed Long Term Share Performance?

If you are wondering whether Cooper Companies' current share price fairly reflects its prospects, you are not alone; many investors are asking the same question right now. The stock recently closed at US$83.47, with returns of 0.1% over 7 days, 3.2% over 30 days and 2.9% year to date, while the 1 year and 5 year returns of an 8.3% decline and a 12.4% decline give a very different impression. Recent news coverage has focused on Cooper Companies' position in the healthcare sector and how...
NYSE:ENR
NYSE:ENRHousehold Products

A Look At Energizer Holdings (ENR) Valuation After Recent Share Price Volatility

Event context and recent share performance Energizer Holdings (ENR) has recently drawn investor attention after a mixed stretch in the share price, with a 3.6% one day decline and a 4.3% fall over the past week, which contrasts with gains over the month and past 3 months. See our latest analysis for Energizer Holdings. Looking beyond the latest pullback, Energizer Holdings’ 20.7% 3 month share price return and 9.6% year to date share price return contrast with a 25.7% 1 year total shareholder...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals Q4 Loss Of US$229 Million Tests Bullish Profitability Narrative

Ionis Pharmaceuticals FY 2025 earnings snapshot Ionis Pharmaceuticals (IONS) closed FY 2025 with fourth quarter revenue of US$203 million and a basic EPS loss of US$1.41, alongside a trailing twelve month revenue base of US$944 million and a TTM basic EPS loss of US$2.38. Over the past year, quarterly revenue has moved between US$131.6 million and US$452.0 million, while basic EPS swung from a profit of US$0.78 in Q2 2025 to losses of US$0.93 in Q1 and US$0.80 in Q3. This sets up a results...
NYSE:CALX
NYSE:CALXCommunications

Calix SmartBiz And SmartTown Rollout Supports Valuation Debate For Investors

Calix (NYSE:CALX) is working with Cablelynx, the broadband arm of WEHCO Video, to deploy its SmartBiz service for small businesses and SmartTown for broader community Wi-Fi. The deployments are aimed at improving secure connectivity, customer engagement, and managed services for local enterprises and residents. This development highlights real world use of the Calix One platform beyond residential broadband, focusing on business transformation and community connectivity. For investors...
NYSE:SHAK
NYSE:SHAKHospitality

Is It Too Late To Consider Shake Shack (SHAK) After Its Premium Valuation Multiple?

If you are wondering whether Shake Shack, at around US$92 a share, is priced for perfection or still offers value, this article walks through what that current price might mean for investors. The stock is at US$92.13 after a 2.2% decline over the last 7 days, a 1.7% gain over 30 days, a 10.4% gain year to date, a 16.4% decline over 1 year, and a 19.1% decline over 5 years, with a 61.4% gain across 3 years. Recent headlines around Shake Shack have focused on the brand's ongoing expansion, new...
NYSE:RHI
NYSE:RHIProfessional Services

Is Robert Half (RHI) Offering Value After A 57% One Year Share Price Slump

If you are wondering whether Robert Half's current share price reflects its real worth, you are not alone. This article focuses squarely on what the numbers say about value. The stock closed at US$23.58, with returns of a 9.0% decline over the past week, 16.8% decline over the past month, 13.8% decline year to date, 57.3% decline over 1 year, 66.6% decline over 3 years, and 63.6% decline over 5 years, which raises obvious questions about how the market is currently pricing the...
NYSE:MIR
NYSE:MIRElectronic

New Global Tariffs Test Mirion Technologies Margins And Valuation Outlook

Mirion Technologies (NYSE:MIR) is facing material trade policy uncertainty after the US administration imposed new 15% global tariffs under the Trade Act of 1974. The tariffs follow a recent Supreme Court ruling and are being implemented abruptly, affecting companies with international supply chains. For Mirion, the policy shift raises questions around cost structure, operational planning, and future financial results. Mirion Technologies, trading at $21.49, now sits at the center of a...
NYSE:SEM
NYSE:SEMHealthcare

Select Medical (SEM) Issues 2026 Outlook After Margin Pressure: Is Its Earnings Power Repositioning?

In February 2026, Select Medical Holdings Corporation reported mixed fourth-quarter and full-year 2025 results, with revenue rising to US$1,396.63 million for the quarter and US$5,452.83 million for the year, while profitability remained under pressure. On the same day, the company declared a US$0.0625 per-share cash dividend and issued 2026 guidance calling for US$5.6 billion to US$5.8 billion in revenue and fully diluted earnings per share of US$1.22 to US$1.32, framing how management sees...
NYSE:XPRO
NYSE:XPROEnergy Services

Expro Buyback And North Africa Contract Reframe Valuation And Cash Flow

Expro Group Holdings (NYSE:XPRO) has authorized a new $100 million share repurchase program. The company has secured a major multi-year contract in North Africa with an initial four-year term. Recent earnings included higher margins and free cash flow, alongside softer revenue in certain regions. Expro Group, a global energy services provider listed on the NYSE as XPRO, is active across well construction, well flow management, and subsea services. The mix of a sizable buyback authorization...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Margin Compression Reinforces Bearish Narrative Despite FY 2025 Revenue Strength

Corcept Therapeutics FY 2025 earnings snapshot Corcept Therapeutics (CORT) has wrapped up FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.24, alongside net income of US$25.4 million. Over the past six quarters, the company has seen revenue move from US$181.9 million in Q4 2024 to a range between US$157.2 million and US$207.6 million per quarter, while basic EPS has ranged between US$0.19 and US$0.45. With a trailing 12 month net profit margin of 13.1% compared to 20.7% a...
NYSE:MCD
NYSE:MCDHospitality

McDonald's (MCD) Margin Steadiness Tested By Premium Valuation After FY 2025 Results

McDonald's (MCD) closed out FY 2025 with fourth quarter revenue of US$7.0 billion and basic EPS of US$3.03, alongside net income of US$2,164 million, setting the tone for a year where trailing 12 month revenue reached US$26.9 billion and EPS came in at US$12.00. Over the past few quarters, revenue has moved from US$5,956 million in Q1 2025 to US$7,078 million in Q3 2025 before landing at US$7,009 million in Q4. Quarterly EPS ranged between US$2.61 and just over US$3.19, with a trailing net...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Trinity Capital (TRIN) Net Margin Slippage Challenges Bullish Profitability Narratives

Trinity Capital (TRIN) closed out FY 2025 with Q4 total revenue of US$77.6 million and basic EPS of US$0.51, alongside trailing twelve month revenue of US$279.5 million and EPS of US$1.96, set against reported earnings growth of 17.3% over the past year. Over recent periods the company has seen revenue move from US$205.2 million on a trailing basis in Q3 2024 to US$226.7 million in Q4 2024 and then to US$279.5 million by Q4 2025. Trailing EPS shifted from US$1.79 to US$2.19 and then to...
NYSE:ABCB
NYSE:ABCBBanks

How Investors May Respond To Ameris Bancorp (ABCB) Leadership Refresh Following Retirement of Strategy Chief

Ameris Bancorp recently announced that Corporate Executive Vice President and Chief Strategy Officer James A. LaHaise will retire on April 30, 2026, with a three-month transition period and retirement benefits under an existing supplemental plan. His departure, alongside the earlier-disclosed retirement of Chief Risk Officer Bill McKendry and internal promotions to fill these roles, highlights an important refresh of Ameris’s leadership bench in strategy, risk, and oversight functions. We’ll...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Exelon PJM Transmission Win Puts Grid Reliability And Debt Trade Offs In Focus

Exelon (NasdaqGS:EXC) and NextEra Energy Transmission received approval from the PJM Board of Directors for a large multi state transmission line project. The project is intended to address electric grid reliability and affordability across a broad region. The new transmission capacity is expected to support future generation projects and help accommodate growing electricity demand. For investors watching utilities, this development sits at the intersection of grid reliability, cost...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

What Neogen (NEOG)'s HYCOAT Recall for Contamination Concerns Means For Shareholders

In February 2026, Neogen Corporation announced a voluntary recall of all in-date lots of its Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution after microbial contamination was detected and adverse events were reported in horses, and the company is working with the FDA while its investigation continues. Management has emphasized that no adverse events have been linked to use strictly following the labeled directions, highlighting how product handling and administration practices may be...
NYSE:GPOR
NYSE:GPOROil and Gas

Gulfport Energy (GPOR) Profit Swing To US$396 Million Challenges Cautious Debt Narrative

Gulfport Energy (GPOR) has wrapped up FY 2025 with fourth quarter revenue of US$355.5 million and basic EPS of US$6.90, alongside net income excluding extra items of US$132.4 million. Over the past year, revenue on a trailing 12 month basis has moved from US$909.2 million in Q4 2024 to US$1.3 billion in Q4 2025, while basic EPS over the same window shifted from a loss of US$14.72 to a profit of US$21.74. This sets up a year in which margins and cash generation are front and center for...
NYSE:HHH
NYSE:HHHReal Estate

Is It Time To Reassess Howard Hughes Holdings (HHH) After Prolonged Share Price Weakness

If you are wondering whether Howard Hughes Holdings is starting to look like value at today's price, or if the market still sees it as a work in progress, this article will walk you through what the numbers are really saying. Despite trading at US$72.77, the stock has seen recent pressure, with returns of a 12.4% decline over 7 days, a 10.2% decline over 30 days, a 7.7% decline year to date and a 1.8% decline over the past year, extending to a 7.5% decline over 3 years and an 18.4% decline...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative

United Therapeutics (UTHR) FY 2025 Earnings Snapshot United Therapeutics (UTHR) closed FY 2025 with fourth quarter revenue of US$790.2 million and basic EPS of US$8.41, capping a twelve month run where trailing revenue reached US$3.2 billion and EPS came in at US$30.13. Over that period, revenue has moved from US$2.9 billion to US$3.2 billion and EPS has shifted from US$26.44 to US$30.13, giving investors a clear view of how the top line and EPS have tracked together. With a net income of...
NasdaqGS:REYN
NasdaqGS:REYNHousehold Products

Reynolds Consumer Products (REYN) Valuation Check After Product Of The Year Recognition

Reynolds Consumer Products and the 2026 Product of the Year win Reynolds Consumer Products (REYN) is back on investors’ radar after its Reynolds Kitchens Parchment Cooking Bags were voted the 2026 Product of the Year in the Kitchen Essentials category, based on feedback from 40,000 American shoppers. See our latest analysis for Reynolds Consumer Products. The Product of the Year recognition comes after a mixed spell for Reynolds Consumer Products, with a 7 day share price return of 2.8% and a...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Pebblebrook Hotel Trust Refinancing Resets Debt Timeline And Liquidity Options

Pebblebrook Hotel Trust (NYSE:PEB) recently completed a $450 million senior unsecured term loan. The company used part of the proceeds to repay certain mortgages and address near term debt maturities. Management also restored full capacity on its revolving credit facility, increasing available liquidity. Pebblebrook Hotel Trust, trading at $12.24, has had mixed share performance, with a 6.0% return year to date and a 4.6% return over the past year, but weaker 3 year and 5 year returns of...
NYSE:PERF
NYSE:PERFSoftware

Is It Time To Reassess Perfect (PERF) After A Multi Year Share Price Slump

If you are wondering whether Perfect's current share price reflects its true worth, this breakdown will help you connect the recent market action to what the numbers actually say about value. Perfect's share price closed at US$1.38, with returns of a 5.5% decline over 7 days, a 17.4% decline over 30 days, a 20.2% decline year to date, a 27.7% decline over 1 year and 81.9% and 86.1% declines over 3 and 5 years. This performance sits against a backdrop of ongoing market attention on software...
NYSE:MTDR
NYSE:MTDROil and Gas

Matador Resources (MTDR) Margin Compression Challenges Bullish Efficiency And Midstream Narratives

Matador Resources (MTDR) has wrapped up FY 2025 with fourth quarter revenue of US$848 million and basic EPS of US$1.55, alongside net income excluding extra items of US$192.5 million. This gives investors a clear read on its latest run rate. Over the past year, total revenue on a trailing twelve month basis has moved from US$3.24 billion in Q4 2024 to US$3.70 billion in Q4 2025, while trailing basic EPS shifted from US$7.16 to US$6.10, framing the current quarter against a fuller year of...